← Back
$APGE All transactions

Apogee Therapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$73K

Shares

1,108

Price

$66

Filed

Feb 4

Insider

Name

Henderson Jane

Title

Chief Financial Officer

CIK

0001422304

Roles

Officer

Transaction Details

Transaction Date

2026-02-02

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

183,471

Footnotes

This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on September 2, 2025. | The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $64.80 to $65.61, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range. | The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $65.84 to $66.75, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.

Filing Info

Accession No.

0001104659-26-010453

Form Type

4

Issuer CIK

0001974640

Henderson Jane's History

Date Ticker Type Value
2026-04-16 APGE $180K
2026-04-01 APGE $76K
2026-04-01 APGE $94K
2026-03-25 APGE $170K
2026-02-02 APGE $52K
2026-02-02 APGE $73K
2026-02-02 APGE $7K
2026-01-06 APGE $160K
2026-01-02 APGE $142K
2026-01-02 APGE $307K

Other Insiders at APGE (90d)

Insider Bought Sold Last
Henderson Jane
Chief Financial Officer
$578K 2026-04-16
HENDERSON MICHAEL THOMAS
Chief Executive Officer
$2.9M 2026-04-16
Dambkowski Carl
Chief Medical Officer
$828K 2026-04-01